Cite Filings / BCRX / 0001140361-25-044111

Feed Companies Filings Check

Sign in

425

Prospectus/Communication re Business Combination

BIOCRYST PHARMACEUTICALS INC Filed 2025-12-03 Acc 0001140361-25-044111

Documents 1

425 Prospectus/Communication re Business Combination , ef20060538_425.htm

Around this filing

2025-12-03 144 Sale of Securities
2025-12-03 425 Prospectus/Communication re Business Combination
2025-12-03 8-K Other events
2025-12-03 4 Chief Legal Officer sold 161,680 shares at an average $7.21 ($1,164,967)
2025-12-02 4 Director acquired 783 shares (grant or award)
2025-12-02 4 Director acquired 1,566 shares (grant or award)
2025-10-14 425 Prospectus/Communication re Business Combination

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading ef20060538_425.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…